Literature DB >> 21202306

2-(1H-Tetra-zol-5-yl)benzonitrile.

Zheng Xing1, Guang-Fan Han, Wei-Feng Zhu, Yu-Yuan Zhao.   

Abstract

The title compound, C(8)H(5)N(5), was synthesized from phthalonitrile. The benzonitrile and tetra-zole rings are inclined at a dihedral angle of 37.14 (11)°. In the crystal structure, inter-molecular N-H⋯N hydrogen bonds link the tetra-zole rings of adjacent mol-ecules, forming chains along the a axis.

Entities:  

Year:  2008        PMID: 21202306      PMCID: PMC2961120          DOI: 10.1107/S1600536808008027

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For backgound to the chemisty of tetra­zoles, see: Bekhit et al. (2004 ▶); Aykut İkizler & Sancak (1992 ▶, 1995 ▶, 1998 ▶); Rajasekaran & Thampi (2004 ▶); Satyanarayana et al. (2006 ▶); Schmidt & Schieffer (2003 ▶); Upadhayaya et al. (2004 ▶); Wexler et al. (1996 ▶).

Experimental

Crystal data

C8H5N5 M = 171.17 Monoclinic, a = 4.9281 (10) Å b = 6.5420 (13) Å c = 24.867 (5) Å β = 95.27 (3)° V = 798.3 (3) Å3 Z = 4 Mo Kα radiation μ = 0.10 mm−1 T = 293 (2) K 0.25 × 0.07 × 0.07 mm

Data collection

Rigaku SCXmini diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku, 2005 ▶) T min = 0.993, T max = 0.996 6844 measured reflections 1553 independent reflections 1167 reflections with I > 2σ(I) R int = 0.061

Refinement

R[F 2 > 2σ(F 2)] = 0.055 wR(F 2) = 0.138 S = 1.10 1553 reflections 122 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.21 e Å−3 Δρmin = −0.24 e Å−3 Data collection: CrystalClear (Rigaku, 2005 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks I, New_Global_Publ_Block. DOI: 10.1107/S1600536808008027/sj2471sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536808008027/sj2471Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H5N5F000 = 352
Mr = 171.17Dx = 1.424 Mg m3
Monoclinic, P21/nMo Kα radiation λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 6584 reflections
a = 4.9281 (10) Åθ = 3.1–28.8º
b = 6.5420 (13) ŵ = 0.10 mm1
c = 24.867 (5) ÅT = 293 (2) K
β = 95.27 (3)ºPrism, colorless
V = 798.3 (3) Å30.25 × 0.07 × 0.07 mm
Z = 4
Rigaku SCXmini diffractometer1553 independent reflections
Radiation source: fine-focus sealed tube1167 reflections with I > 2σ(I)
Monochromator: graphiteRint = 0.061
Detector resolution: 13.6612 pixels mm-1θmax = 26.0º
T = 293(2) Kθmin = 3.2º
ω scansh = −6→6
Absorption correction: multi-scan(CrystalClear; Rigaku, 2005)k = −8→8
Tmin = 0.993, Tmax = 0.996l = −30→30
6844 measured reflections
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH atoms treated by a mixture of independent and constrained refinement
R[F2 > 2σ(F2)] = 0.055  w = 1/[σ2(Fo2) + (0.0619P)2 + 0.1285P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.138(Δ/σ)max < 0.001
S = 1.10Δρmax = 0.21 e Å3
1553 reflectionsΔρmin = −0.24 e Å3
122 parametersExtinction correction: SHELXL
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.044 (14)
Secondary atom site location: difference Fourier map
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.5249 (4)0.5054 (3)0.13602 (8)0.0345 (5)
C20.6569 (4)0.5277 (3)0.08892 (8)0.0403 (5)
C30.6021 (5)0.6960 (4)0.05536 (10)0.0548 (7)
H30.69250.71160.02440.066*
C40.4141 (5)0.8390 (4)0.06821 (11)0.0608 (7)
H40.37620.95090.04570.073*
C50.2821 (5)0.8174 (4)0.11410 (11)0.0539 (6)
H50.15370.91400.12230.065*
C60.3384 (4)0.6532 (3)0.14819 (9)0.0441 (6)
H60.25040.64160.17960.053*
C70.5736 (4)0.3299 (3)0.17202 (8)0.0323 (5)
C80.8482 (5)0.3773 (4)0.07280 (9)0.0476 (6)
N10.9990 (5)0.2612 (4)0.05847 (9)0.0701 (7)
N20.3814 (3)0.2405 (3)0.19806 (7)0.0399 (5)
N30.4920 (3)0.0893 (3)0.22916 (8)0.0480 (5)
N40.7498 (3)0.0881 (3)0.22217 (7)0.0458 (5)
N50.8068 (3)0.2363 (3)0.18650 (7)0.0380 (5)
H20.195 (6)0.253 (4)0.1939 (10)0.072 (8)*
U11U22U33U12U13U23
C10.0263 (10)0.0405 (11)0.0363 (11)0.0019 (9)0.0016 (8)0.0010 (9)
C20.0345 (12)0.0463 (12)0.0407 (12)0.0040 (10)0.0062 (9)0.0018 (10)
C30.0598 (16)0.0595 (15)0.0473 (14)0.0110 (12)0.0171 (12)0.0137 (12)
C40.0658 (17)0.0558 (15)0.0611 (17)0.0139 (13)0.0072 (14)0.0187 (13)
C50.0491 (14)0.0480 (14)0.0642 (16)0.0144 (11)0.0041 (12)−0.0003 (12)
C60.0397 (12)0.0507 (13)0.0425 (13)0.0070 (10)0.0069 (10)−0.0014 (10)
C70.0221 (9)0.0434 (11)0.0319 (11)0.0004 (8)0.0055 (8)−0.0021 (9)
C80.0476 (13)0.0573 (15)0.0395 (13)0.0069 (12)0.0127 (10)0.0069 (11)
N10.0705 (15)0.0809 (15)0.0623 (15)0.0288 (13)0.0242 (12)0.0062 (12)
N20.0203 (9)0.0531 (11)0.0468 (11)0.0024 (8)0.0058 (8)0.0107 (8)
N30.0306 (9)0.0600 (12)0.0540 (12)0.0029 (9)0.0074 (8)0.0166 (10)
N40.0296 (9)0.0583 (12)0.0494 (11)0.0047 (8)0.0042 (8)0.0139 (9)
N50.0238 (8)0.0510 (10)0.0400 (10)0.0035 (8)0.0065 (7)0.0070 (8)
C1—C61.386 (3)C5—H50.9300
C1—C21.399 (3)C6—H60.9300
C1—C71.462 (3)C7—N51.323 (2)
C2—C31.393 (3)C7—N21.331 (2)
C2—C81.445 (3)C8—N11.142 (3)
C3—C41.375 (3)N2—N31.340 (2)
C3—H30.9300N2—H20.92 (3)
C4—C51.372 (3)N3—N41.298 (2)
C4—H40.9300N4—N51.361 (2)
C5—C61.381 (3)
C6—C1—C2118.61 (19)C6—C5—H5119.8
C6—C1—C7119.24 (18)C5—C6—C1120.5 (2)
C2—C1—C7122.13 (17)C5—C6—H6119.7
C3—C2—C1120.31 (19)C1—C6—H6119.7
C3—C2—C8117.86 (19)N5—C7—N2107.65 (17)
C1—C2—C8121.81 (19)N5—C7—C1128.31 (17)
C4—C3—C2119.7 (2)N2—C7—C1123.99 (17)
C4—C3—H3120.1N1—C8—C2177.8 (2)
C2—C3—H3120.1C7—N2—N3109.61 (16)
C5—C4—C3120.3 (2)C7—N2—H2130.9 (16)
C5—C4—H4119.9N3—N2—H2118.7 (16)
C3—C4—H4119.9N4—N3—N2106.16 (16)
C4—C5—C6120.5 (2)N3—N4—N5110.25 (16)
C4—C5—H5119.8C7—N5—N4106.33 (15)
C6—C1—C2—C30.4 (3)C6—C1—C7—N5−141.7 (2)
C7—C1—C2—C3179.22 (19)C2—C1—C7—N539.5 (3)
C6—C1—C2—C8−178.3 (2)C6—C1—C7—N235.6 (3)
C7—C1—C2—C80.5 (3)C2—C1—C7—N2−143.2 (2)
C1—C2—C3—C4−1.1 (4)N5—C7—N2—N3−0.1 (2)
C8—C2—C3—C4177.7 (2)C1—C7—N2—N3−177.85 (18)
C2—C3—C4—C50.5 (4)C7—N2—N3—N40.3 (2)
C3—C4—C5—C60.7 (4)N2—N3—N4—N5−0.4 (2)
C4—C5—C6—C1−1.3 (4)N2—C7—N5—N4−0.2 (2)
C2—C1—C6—C50.8 (3)C1—C7—N5—N4177.48 (19)
C7—C1—C6—C5−178.05 (19)N3—N4—N5—C70.4 (2)
D—H···AD—HH···AD···AD—H···A
N2—H2···N5i0.92 (3)1.91 (3)2.820 (2)172 (2)
N2—H2···N4i0.92 (3)2.60 (3)3.374 (2)142 (2)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H2⋯N5i0.92 (3)1.91 (3)2.820 (2)172 (2)
N2—H2⋯N4i0.92 (3)2.60 (3)3.374 (2)142 (2)

Symmetry code: (i) .

  6 in total

Review 1.  Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

Authors:  Boris Schmidt; Bernhard Schieffer
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

2.  Synthesis of novel substituted tetrazoles having antifungal activity.

Authors:  Ram Shankar Upadhayaya; Sanjay Jain; Neelima Sinha; Nawal Kishore; Ramesh Chandra; Sudershan K Arora
Journal:  Eur J Med Chem       Date:  2004-07       Impact factor: 6.514

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 4.  Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.

Authors:  R R Wexler; W J Greenlee; J D Irvin; M R Goldberg; K Prendergast; R D Smith; P B Timmermans
Journal:  J Med Chem       Date:  1996-02-02       Impact factor: 7.446

5.  Tetrazolo[1,5-a]quinoline as a potential promising new scaffold for the synthesis of novel anti-inflammatory and antibacterial agents.

Authors:  Adnan A Bekhit; Ola A El-Sayed; Elsayed Aboulmagd; Ji Young Park
Journal:  Eur J Med Chem       Date:  2004-03       Impact factor: 6.514

6.  Synthesis and analgesic evaluation of some 5-[beta-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-tetrazoles.

Authors:  A Rajasekaran; P P Thampi
Journal:  Eur J Med Chem       Date:  2004-03       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.